Growth Stocks Hit by Rates
Surging oil prices and sticky producer inflation are pushing bond yields higher, pressuring rate-sensitive growth valuations across healthcare technology.
Previous verdicts for DXCM
- AI Search: DexCom drifts lower as analysts remain divided on the stock — 2026-10-06
- CGM headwinds weigh on DXCM — 2026-09-29
- DXCM Climbs on Exec Promotion — 2026-09-15
- Japan approval lifts DXCM — 2026-09-14
- Risk-off hits growth — 2026-09-08
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works